BioMarin Pharmaceutical Earning Date (BMRN)

USA |NASDAQ |USD

BMRN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 26, 2022 Jun 2022 $0.16 - $0.53
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 26, 2022 Jun 2022 $522.39M - $501.69M

Biomarin Pharmaceutical's next earnings date is Tuesday, Jul 26, 2022 for the fiscal quarter ending Jun 2022.

BMRN Earnings Date & History Chart

BMRN Earnings & Revenue Forecast

BMRN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 14 $0.16 $-0.03 $0.57
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 17 $0.73 $-0.22 $2.57
Dec 2023 18 $2.75 $0.12 $7.12

BMRN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 0 $0.19 $0.03 $0.00
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $0.87 $0.54 $0.44
Dec 2023 1 / 0 $2.89 $2.41 $2.41

BMRN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 16 $522.39M $494.82M $554.20M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 20 $2.10B $1.92B $2.26B
Dec 2023 21 $2.80B $2.21B $3.89B

BMRN Earnings Date & Revenue History

BMRN Earnings History

|
Show More
Show More

BMRN Revenue History

|
Show More
Show More

Biomarin Pharmaceutical Next Earnings Date & Report

BMRN Next Earnings Date & Report Preview: Jun 2022 (FQ)

BMRN's next earnings date is Tuesday, Jul 26, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Biomarin Pharmaceutical's next quarterly earnings is $0.16, with a low EPS estimation of $-0.03, and a high estimation of $0.57.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $0.19, the last 2 month trend is $0.03, and the 3 month trend is $0.00.

Based on analysts, the average revenue estimation is $522.39M, with a low revenue estimation of $494.82M, and a high estimation of $554.20M.

Biomarin Pharmaceutical Previous Earnings Dates & Reports

BMRN Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Biomarin Pharmaceutical's previous earnings date was Apr 27, 2022 for its fiscal quarter ended Mar 31, 2022.

BMRN Previous Earnings Date & Report Recap: Dec 2021 (FY)

Biomarin Pharmaceutical's previous annual earnings date was Feb 23, 2022 for its fiscal year ended Dec 31, 2021.

BMRN's earnings per share (EPS) was $0.96, beating the consensus analysts forecast of $-0.37 by -358.51% , and lower than the previous year's EPS (Dec 2020) by -42.15%.

Revenues were $1.85B, better than the forecast of $1.84B by 0.35%, and down by -0.76% from previous year's revenue.

The company reported a net income of $-64.08M.

Biomarin Pharmaceutical reported a free cash flow of $185.31M for its fiscal year, compared to $-52.15M a year ago.

The company ended the fiscal year with $1.09B in total debt, an increase of 0.24% compared to the previous year.